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Neuroscientific explanations of gambling disorder can help people make sense of their experiences and guide the 
development of psychosocial interventions. However, the societal perceptions and implications of these explanations 
are not always clear or helpful. Two workshops in 2013 and 2014 brought together multidisciplinary researchers 
aiming to improve the clinical and policy-related effects of neuroscience research on gambling. The workshops 
revealed that neuroscience can be used to improve identification of the dangers of products used in gambling. 
Additionally, there was optimism associated with the diagnostic and prognostic uses of neuroscience in problem 
gambling and the provision of novel tools (eg, virtual reality) to assess the effectiveness of new policy interventions 
before their implementation. Other messages from these workshops were that neuroscientific models of decision 
making could provide a strong rationale for precommitment strategies and that interdisciplinary collaborations are 
needed to reduce the harms of gambling.
Introduction
In DSM-5,1 gambling disorder (hereafter referred to as 
problem gambling) is classified in the Addiction and 
Related Disorders category, within a subcategory of non-
substance-related disorders. The reclassification of 
pathological gambling from an Impulse Control Disorder 
in DSM-IV was based on growing evidence from empirical 
observations that behavioural addictions, such as problem 
gambling, show similarities (including brain processes) to 
alcohol and other drug addictions.2,3 Yet, compared with 
the large research initiatives in drug addiction (eg, the 
Dutch NEXT study4 of ecstasy and the US ABCD study5 of 
substance addiction), problem gambling remains largely 
descriptive and poorly integrated, with research often 
failing to translate into clinical or policy interventions. To 
address this paucity of research, a multidisciplinary 
international consortium of 25 gambling and addiction 
researchers—from neuroscience, economics, public 
health, and health policy—and clinicians, met at two 
workshops (called Problem gambling: an interdisciplinary 
dialogue between neuroscientists, clinicians and policy makers) 
in 2013 and 2014 in Melbourne, Australia. Here, we 
present the key findings of these two workshops.
Gambling workshop 2013: scoping the field
The first workshop outlined the gambling-related issues 
faced by scientists, clinicians, and policy makers. According 
to the Australian Productivity Commission,6 gambling 
raises about AUS$19 billion in revenue per year in 
Australia, 55% of which flows through electronic gaming 
machines (EGMs) in clubs and hotels. Despite substantial 
gambling-related harms and associated costs, gambling is 
estimated to yield a net benefit to the Australian economy 
of $4–11 billion per year, although these benefits do not 
take into account secondary costs, such as those associated 
with suicide, divorce, and loss of social capital.6 The 
extremely low prevalence of severe or pathological 
gambling in Australia (about 0·6%, depending on the 
jurisdiction)7 also grossly misrepresents the scale of the 
problem among people who use EGMs. The prevalence of 
problem gambling in people who use EGMs in Australia is 
as high as 15% and high-intensity machines allow losses of 
up to $12 000 each hour.6 Although only 0·6% of 
Australians are thought to be problem gamblers, this 
group accounts for an estimated 40% of monetary losses 
on EGMs.6 Similar patterns are found in most Western 
countries.8
Clinical outcomes are adversely affected by stigma and 
shame around problem gambling in the community and 
workplace. Treatment seeking for gambling among 
individuals with gambling disorders is low (<10%9), and is 
lower than for substance use disorders and other mental-
health disorders.10 Similar to other drug addictions,11 natural 
recovery is common: most affected individuals follow a 
transitory, episodic pattern of gambling, rather than an 
enduring and chronic pattern.12 It is unclear whether the 
repeated-episodes pattern of problem gambling is due to 
the natural course of the underlying addictive process or to 
external constraints on continued excessive gambling that 
emerge as problem gamblers deplete their financial 
resources and access to credit. The process of treatment-
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assisted recovery is similar to other addictions in that 
problem gamblers rely on several approaches to overcome 
their condition. Psychotherapies (ie, cognitive behavioural 
therapy or brief interventions) are moderately effective for 
the treatment of problem gambling, and pharmacological 
treatments (eg, naltrexone, naloxone, and nalmefene) have 
shown some effectiveness.8,13 Further research is required 
to uncover the neurobiological mechanisms that sustain 
excessive gambling and how these mechanisms might be 
interrupted by various treatment methods to determine 
how to prevent problem gambling and deliver the most 
effective services.
Implications of neuroscience for treatment
Problem gambling is associated with several cognitive 
impairments, including diminished reward sensitivity 
(associated with reduced activity in the reward circuits), 
reduced ability to delay reward or learn from negative 
consequences, stronger physiological responses to near 
wins, and poor error monitoring.14 Furthermore, co-
occurring and chronic substance use might exacerbate 
cognitive impairments associated with problem 
gambling and complicate treatment and recovery. At the 
workshop we recognised the neuropsychological effect of 
near wins on the development and maintenance of 
gambling addiction as a key feature of problem gambling. 
Modern EGMs are carefully engineered to give players an 
illusory sense of control over reinforcement rates despite 
fixed payback percentages, and the type of players who 
are the most susceptible to acquiring the habit of 
excessive gambling are also those who are the most 
sensitive to such design elements.15 The limitations of 
neuroscience research in gambling include the presence 
of conflicting findings that are often ignored—a major 
concern given the prevalence of false positives.16,17 
Increased impulsivity in problem gamblers seeking 
treatment versus problem gamblers in the general 
community might explain some of the variation in 
research findings18,19 and warrants further investigation 
(eg, treatment-seeking vs non-treatment-seeking or 
relapsing vs non-relapsing problem gamblers).20 Views 
on the clinical and policy implications of this research 
were similarly cautious.
We regarded treatment matching with biomarkers as 
premature, with further evidence from clinical trials 
needed.21,22 The identification of gambling subtypes (ie, 
mild, moderate, severe, or pathways models23) was deemed 
a promising area of investigation, which might yield better 
treatment outcomes. Optimism was held for treatments 
emerging from neuroscience research, particularly those 
that exploit targeted cognitive therapies, such as 
neurostimulation or neurofeedback.24 Neuroscience might 
also provide novel tools (eg, virtual reality) to assess the 
effectiveness of new clinical or policy interventions before 
their implementation or allow the evidence-based 
development of less harmful gambling products (eg, less 
harmful EGMs).
Implications of neuroscience for policy
The inclusion of problem gambling disorders as a 
behavioural addiction in DSM-5 was controversial. The 
effect of ratifying gambling disorder as an addiction on 
most insurance policies remains unclear. For example, 
the Affordable Health Care and Mental Health Parity and 
Addiction Equity Acts ensure that all US citizens receive 
the same level of benefits for mental or substance-use 
treatment as for traditional medical services. It is unclear 
whether the reclassification of gambling within the 
category of Addiction and Related Disorders will ensure 
that people with gambling disorders are covered by the 
increased medical insurance coverage in the USA.
Characterisation of gambling as an addiction also 
affects research. As workshop participants pointed out, 
neurobiological studies of problem gambling could focus 
on the addictive properties of the machines. Although 
the precise level of addictiveness of EGMs is debated in 
the scientific literature,25 there was widespread consensus 
at the workshops that EGMs represent the most harmful 
and dangerous form of gambling activity. The practice of 
programming high numbers of near wins into EGMs 
was banned in the USA in 1989 following the presentation 
of findings from psychosocial research to the Nevada 
Gaming Commission in 1988.26 We viewed modification 
of the characteristics of gambling products as being an 
effective and efficient way for reducing gambling-related 
harm—for example, the highly addictive elements of 
EGMs could be dampened to make less addictive and 
safer EGMs (eg, less frequent near wins, visual reminders 
of the money and time spent on a machine, or limits on 
total losses). Modifying the characteristics of gambling 
products to reduce gambling-related harm would require 
governments with the regulatory willpower to compel 
industry to make such changes.
A major challenge for policy makers is that benefits 
and harms are not objective and require consideration of 
moral qualities, such as justice and respect for persons. 
Gambling is a regressive form of resource redistribution 
that tends to extract the greatest resources and cause the 
greatest harm in socially disadvantaged areas, which is 
where EGMs are most concentrated.6 Effective policy 
should support a sustainable gambling industry to 
maximise benefits, including personal enjoyment, while 
minimising harms.
Policy must also be practical and achievable, which 
requires the balancing of pragmatic concerns, including 
the role or influence of vested interests such as industry 
and government. Although it is common not to accept 
industry contributions to alcohol and tobacco research, 
this practice is not seen for gambling research.27 
Gambling research receives minimal government 
support and is often funded through taxes on the 
proceeds of gambling. Acknowledging that industry 
funding can bias research, we could not reach a 
consensus about the appropriateness of receiving 
industry contributions for the support of gambling 
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research or treatment. This discussion was continued 
outside of the workshops and led to a paper.27
Greater transparency and guidance is needed about 
when and how it might be permissible to accept industry 
funding. Such guidance might include development of 
research funding guidelines that receive widespread 
support, as has occurred in other areas of addiction 
research.28,29 More research is needed to determine the 
best strategies for policy implementation because of the 
inherent difficulties in identifying whose responsibility it 
is to implement policy. Moreover, potential conflicting 
interests pervade the policy-implementation landscape. 
Two areas in which policy change could be made quickly 
and easily, providing that there is the necessary political 
will, are addressing the advertisement of gambling 
products and making the process for appealing gaming 
licences more accessible and transparent.
Gambling workshop 2014: key challenges
The 2014 workshop explored in greater detail three key 
topics that were identified in the 2013 workshop: the 
neuroscience of EGMs, the utility of subtyping to 
improve clinical treatment, and precommitment policy 
interventions. The aim was to understand how best to 
implement change in these areas.
Neuroscience of EGMs
We regarded EGMs as the source of the greatest harm in 
gambling, a view that was supported by both clinical and 
epidemiological evidence.25,30,31 EGMs have a sophisticated 
design in terms of the game and environmental settings 
that keep people using them.32 Research to examine the 
characteristics of modern EGMs and how they exploit 
human cognitive properties is needed. Various features of 
EGMs elicit gambling-related cognitive distortions that 
perpetuate gambling, including traditional near-win (or 
near-miss) outcomes33 and, on modern multiline slot 
machines, “loss disguised as a win” (ie, when the amount 
won is less than the spin wager, but the event is 
accompanied by reinforcing sights and sounds similar to 
a win).34 Studies that used psychophysiology (skin 
conductance, heart rate) and neuroimaging techniques 
found that these game events (near wins and loss 
disguised as a win) activate the sympathetic nervous 
system and recruit reward-related neural circuitry,35,36 and 
that these responses were amplified in participants with 
problem gambling.37
Pathological decision making can emerge from a 
dysregulated executive system, which can be difficult to 
alter. For instance, individuals often interpret near wins 
as evidence that they are mastering the game, which in 
turn fosters an illusion of control.38 Losses disguised as 
wins are particularly pernicious because they undermine 
the decision-making capacity of individuals who are 
already experiencing cognitive distortions and thereby 
impair their ability to make rational choices.34,39 A general 
consensus of the workshop was that losses disguised as 
wins are an area in which policy makers in most 
jurisdictions could easily and quickly make changes to 
the regulations that determine how EGMs operate. It was 
also noted that it should not be necessary to rely on 
neuroscientific explanations because of robust 
behavioural data showing that losses disguised as wins 
undermine the decision-making capacity of the gambler.
A potential advantage of research about the neuroscience 
of EGMs was increased focus on the machine or gambling 
activity as both a target of much needed policy intervention 
and a priority for additional research. The neuroscience of 
decision making and the sophisticated engineering of 
EGMs to exploit the poor decision making of gamblers 
might provide an important motivation for governments 
and policy makers to address the highly addictive nature 
of EGMs. Some participants, however, raised concerns 
that neuroscience, particularly the brain-disease model of 
gambling, might focus attention on the individual 
gambler and deflect attention from addressing agents of 
gambling addiction (eg, EGMs).40
Although we have a greater understanding of why 
EGMs are dangerous, questions remain: how do we 
address the harmfulness of these machines? Do we ask 
governments to legislate to remove the harmful elements 
from the machines, and if so which ones? Or, do we 
simply require manufacturers to include prominent 
warning messages on the machines that state that they 
are harmful?
Validity and utility of subtyping to improve clinical 
treatment
The treatment of problem gambling is complicated by 
substantial heterogeneity, much of which is due to high 
rates of comorbidity with other psychiatric disorders. 
Several theoretical typologies of problem gambling, such 
as the pathways model23 and the clinical typology 
proposed by Dannon and colleagues,41 have tried to 
account for this heterogeneity. The pathways model 
includes three subpopulations: behaviourally conditioned 
problem gamblers; emotionally vulnerable problem 
gamblers; and antisocial, impulsive problem gamblers. 
The recognition of subpopulations of problem gamblers 
might help advance our understanding of the aetiology 
and course of problem gambling, facilitate the study of 
genetic and neurobiological mechanisms, and allow for 
investigation of differential responsiveness to treatment. 
Although the pathways model42,43 outlines a strong 
convergent validity for the three subtypes, subtyping 
remains a promising theory and the focus of important 
scientific research. We concluded that the available 
evidence does not support the routine use of subtyping 
in clinical practice.
We felt the greatest challenge to gambling treatment is 
getting and keeping individuals in treatment. Although 
intensive interventions can be more effective than brief 
interventions (ie, <10 min), even brief or online 
interventions can substantially reduce the severity of 
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problem gambling.44 We believe that greater emphasis on 
low-cost, non-intensive interventions is needed, with 
more intensive interventions reserved for those who do 
not respond to the less intensive approaches.
Precommitment policy interventions
Precommitment interventions that enable gamblers to 
adhere to their self-imposed limits have received 
substantial attention worldwide.45 Various precommitment 
models (eg, full, partial, mandatory, voluntary, or hybrid) 
with different features (eg, spend or time limits) have 
been proposed. These models are typically based on 
behavioural economic theories, such as dual-process 
models of cognition.46 Such models postulate that 
decision making is a function of both experiential and 
affective processes (intuitive system) and analytical and 
deliberative processes (rational system). Impulsive 
behaviour emerges when the intuitive system dominates 
decision making, which is often triggered by arousal after 
exposure to situational cues (eg, in gambling venues). In 
this framework, precommitment strategies enable 
problem gamblers to adhere to rational decisions made at 
times of low arousal and to avoid being overwhelmed by 
increased cognitive and emotional arousal while 
gambling that can lead them to focus on immediate 
reward at the expense of longer-term goals. Unfortunately, 
research about precommitment is often undermined by 
poor study design, such as inadequate study duration or 
politically driven changes in trial implementation,47 as 
occurred in the abandonment of a trial of mandatory 
precommitment in Australia.48 Therefore, substantial 
uncertainty about the efficacy of various precommitment 
strategies remains. Evidence from decision neuro-
science49,50 casts doubt on the validity of dual-process 
models, on which pre-commitment mechanisms are 
based, and has suggested that current interventions 
might need to be reconsidered. Attributing problem 
gambling solely to a breakdown of impulse control, as the 
dual-process model suggests, is misleading because it 
ignores other, more potent aspects of the disorder, 
including compulsivity and learning deficiencies.14,36,37,39
Promises and pitfalls of neuroscience research on 
gambling
Neuroscience may provide new methods to identify people 
at increased risk of developing a gambling disorder, new 
targeted treatments, or better methods to match problem 
gamblers to treatments. However, caution is needed to 
ensure that the search for neurobiological targets does not 
divert attention from the social drivers of gambling or 
population-based approaches to the prevention of 
gambling-related harm. We should also avoid an exclusive 
focus on the individual problem gambler at the expense of 
gambling products as possible targets for intervention.
There was broad agreement that the most promising 
focus for neuroscience research was to further our 
understanding of how EGMs work and help to design 
machines and policies on EGMs that minimise harms. 
Suggestions included use of neuroscience to develop 
less harmful or reinforcing machines and provision of 
rating scales to assess the harmfulness of different 
gambling products.
A major impediment to gambling research is poor 
access to industry products and data. Epidemiological 
data about the prevalence of gambling and amount of 
money lost over periods of time and by whom are 
essential for the development of effective policies to 
reduce gambling-associated harm. Governments could 
require the gambling industry to collect and provide data 
on the gambling incomes of licensed venues to 
government agencies, which could be used in scientific 
research. Access to data about EGM characteristics (ie, 
game type, reinforcement schedule) would enable 
researchers to determine how different characteristics 
are related to gambling behaviour and how changing 
certain aspects of EGMs would alter problematic 
gambling behaviours.
Neuroscience has been seen by government officials 
and policy makers to provide a strong rationale for 
precommitment strategies45 by acknowledging the effect 
that increased cognitive and emotional arousal during 
gambling can have on overriding rational decisions about 
long-term goals. Neuroscience might be used to argue 
that gambling products, especially EGMs, are not an 
ordinary commodity and that their use should be 
carefully regulated similar to other addictive products 
(eg, alcohol and tobacco).
Neurobiological explanations of mental illness have 
been shown to have substantial and often adverse 
effects on the attitudes that clinicians and members of 
the general public have towards people with an 
addiction.51,52 In the absence of public understanding 
that the brain is plastic and malleable, especially with 
abstinence,53 such explanations could increase stigma 
by suggesting that problem gamblers are unable to 
control their behaviour as a result of it being hardwired 
in their brains.54 Future research will need to address 
the social effects of neuroscience on public under-
standing of problem gambling.
Use of neuroscience to influence policy
A crucial question is how we can ensure that our research 
findings are heard and acted on by policy makers in 
relevant topics (eg, machine design, definition of safer 
gambling, venue environment, and person—
environment interaction). To enact change, research 
must produce results that can be acted on in a timely 
manner and have clear links to recommended outcomes. 
Researchers should also consider multiple methods of 
disseminating findings to increase the likelihood that 
they are seen and understood by policy makers.
Gambling disorder is highly comorbid with other 
mental illnesses, yet it is often left out of treatment-
related and other research about addiction and mental 
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health. Thus, there is an urgent need to link gambling 
research and treatment with other areas (eg, alcohol, 
mental health) and incorporate its questions into large 
longitudinal studies.
Researchers need to broaden the definition of harm to 
include gamblers at low and moderate risk of harm, 
because this is the population on which we can have the 
greatest effect and which includes individuals who might 
go on to become more severely disordered gamblers. 
Broadening awareness of the scale of the gambling 
problem is essential, if we are to demonstrate to policy 
makers the importance of the issue and the extent of 
social harm that problem gambling causes.
It is also important to determine what constitutes 
sufficient evidence for enacting policy change. Researchers 
need to educate and inform policy makers about the 
various levels of scientific evidence and the characteristics 
of good-quality research. Researchers are best placed to 
provide the most comprehensive overview of current 
evidence, which might balance the messages and 
viewpoints that policy makers receive from more vested 
interests (eg, industry). However, researchers must 
clearly articulate this evidence in short, easily digestible, 
briefing documents.
Conclusions
Insights from neuroscience can help clinicians and 
patients make sense of gambling disorder and take steps 
to reduce or eliminate harmful gambling behaviours, 
while also providing a rationale for psychosocial 
interventions. However, clear evidence of the effect that 
messages based on neurobiological research have on the 
behaviour of problem gamblers and the wider society is 
scarce. More research is needed to examine at whom 
neurobiologically informed messages should be aimed 
and how they should be delivered. Although neuroscience 
has shown that disordered gamblers have cognitive 
impairments, gambling behaviour is also driven by 
environmental and emotional cues, which should be 
addressed as well.
A recurring theme of the workshops was the need for 
an explicit definition of the overarching aim or philosophy 
when addressing gambling. The language used to 
describe this goal can be instructive. Stakeholders often 
use the phrase responsible gambling, but many 
stakeholders have different concepts of who is 
responsible and what responsible gambling entails. 
Responsibility might refer to corporate responsibility, 
such as responsibility of the venue or industry to provide 
safe gambling environments and products. By contrast, 
the industry stresses the role of the individual in 
gambling responsibly. Neuroscience can be used to focus 
attention on the minority of individuals at increased risk 
of developing problem gambling (the industry-supported 
view) or on the dangers of products used in gambling. 
Neuroscience researchers need to ensure that the 
industry-driven view does not predominate.
A consistent message from these workshops was the 
need for interdisciplinary collaborations to reduce the 
harms of gambling and ensure that researchers ask 
appropriate questions. Interdisciplinary collaborations 
broaden our understanding of the issues involved in 
addressing gambling and improve our interpretation 
and design of scientific studies. Interdisciplinarity is 
also necessary to manage complex data sets that require 
a wide range of research skills. This message should 
be heeded by researchers, clinicians, and funding 
agencies. In the meantime, we will continue to bring 
this consortium together and link it to the biannual 
Victorian Responsible Gambling Foundation national 
conference to grow this interdisciplinary capacity 
and cohesion.
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